The Study on the Effectiveness and Safety of Electroacupuncture at ST36 in Treating Primary Premature Ejaculation

Last updated: January 12, 2024
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Overall Status: Active - Recruiting

Phase

N/A

Condition

Premature Ejaculation

Treatment

Electroacupuncture at ST36

Clinical Study ID

NCT06172855
2022-LCYJ-PY-26
  • Ages 18-60
  • Male

Study Summary

A pilot prospective single-arm cohort study on the Effectiveness and Safety of Electroacupuncture at ST36(Zusanli) in Treating Primary Premature Ejaculation

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age 18 to 60
  2. Heterosexual, with a single, stable partner for more than 6 months
  3. Symptoms of primary premature ejaculation: Complaints of IELT ≤ 1 min since the firstsexual intercourse, and poor ability to control ejaculation leading to anxiety,annoyance, depression or/and avoidance of sexual life and other negative effects.

Exclusion

Exclusion Criteria:

  1. Urinary system infection: Urinary tract infection symptoms (such as urinary tractirritation symptoms, prostatitis symptoms, blood semen, etc.) or urine routine showsabnormal white blood cells and red blood cells
  2. Abnormal androgen: sex hormone examination shows abnormal androgen (testosterone)
  3. Systemic diseases: ask about medical history of hypertension, diabetes, alcoholdependence, coronary heart disease and mental disorders
  4. Organic abnormalities: Abnormal development of external genitalia, bilateral testes,epididymis and spermatic cords with obvious abnormalities on palpation
  5. History of surgery and trauma: Dorsal nerve block of the penis, erectilefunction-related surgery, prostate surgery, pelvic surgery, etc.
  6. Influence of drugs: within one month before enrollment, have taken SSRI, tramadol andother drugs to treat diseases
  7. Allergy to dapoxetine and lidocaine
  8. History of drug, alcohol or substance abuse in the past 6 months
  9. Accompanied by erectile dysfunction: International Index of Erectile Function-5 (International Index of Erectile Function, IIEF-5) score ≤ 21 points

Study Design

Total Participants: 35
Treatment Group(s): 1
Primary Treatment: Electroacupuncture at ST36
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
December 30, 2025

Study Description

This is a pilot prospective single-arm cohort study to verify the Effectiveness and Safety of Electroacupuncture at ST36(Zusanli) in Treating Primary Premature Ejaculation, based on the result on animal study that daily electroacupuncture at ST36(Zusanli) for 30 days could delay the ejaculation of male SD rats.

Connect with a study center

  • Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School

    Nanjing, Jiangsu 210053
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.